BDBM726105 [3a(4)Z,10R]-6,9,10,15-tetramethyl-3,8- dioxo-3,5,8,9,10,11,13,15-octahydro-2H- 1,17-(ethanediylidene)pyrazolo[4,3- m]dipyrrolo[3,2-f:3'',4''- i][1,4]oxazacyclopentadecine-20- carbonitrile::US20250074920, Compound 10

SMILES Cc1cc2c([nH]1)/C=C1/C(=O)Nc3c(C#N)cc(cc31)-c1cn(C)nc1COC[C@@H](C)N(C)C2=O

InChI Key InChIKey=UPGYLNNCCRAXDB-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 726105   

TargetNon-receptor tyrosine-protein kinase TYK2 [888-1187](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726105BDBM726105([3a(4)Z,10R]-6,9,10,15-tetramethyl-3,8- dioxo-3,5,...)
Affinity DataKd:  46nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3 [521-781](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726105BDBM726105([3a(4)Z,10R]-6,9,10,15-tetramethyl-3,8- dioxo-3,5,...)
Affinity DataKd: >1.00E+3nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1 [583-855](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726105BDBM726105([3a(4)Z,10R]-6,9,10,15-tetramethyl-3,8- dioxo-3,5,...)
Affinity DataKd: >1.00E+3nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2 [536-812](Human)
Blossomhill Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 726105BDBM726105([3a(4)Z,10R]-6,9,10,15-tetramethyl-3,8- dioxo-3,5,...)
Affinity DataKd: >1.00E+3nMAssay Description:Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17×PBS, 0.05...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/10/2025
Entry Details
US Patent